Sep 30, 2021 / 04:40PM GMT
Charles Duncan - Cantor Fitzgerald - Analyst
Hello. Welcome to the Cantor Global Healthcare Conference for 2021. My name is Charles Duncan. I'm a managing director and senior biotechnology analyst with the firm. And today is day four of the conference, and it's been quite a conference. And it's been quite a year, actually, for us and many, many folks since we last hosted our clients in the fall of 2020. And so it's a pleasure to introduce the next presenting company, that being Inovio Pharmaceuticals. And with me today, I have the pleasure to introduce the Company's CEO, Dr. Joseph Kim. Joe, how are you doing?
Joseph Kim - Inovio Pharmaceuticals, Inc. - President, CEO & Director
Hi, Charles. Great to be here. I'm doing great, thank you.
Questions and Answers:
Charles Duncan - Cantor Fitzgerald - AnalystYes. Good. Greetings to you. And yes, it's been quite a year. Wow, lots of -- well, lots of challenge for a lot of people, for sure. But then also some real interesting innovation that has been positive to
Trustpilot
